Study ID: TV48125-CNS-30057 | 2016-003171-21

Study Title

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Teva Identifier

TV48125-CNS-30057 | 2016-003171-21

ClinicalTrials.gov Identifier

NCT02964338

Study Status

Terminated

Trial Condition(s)

Chronic Cluster Headache

Interventions

Drug: Fremanezumab | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 70 Years

Trial Duration

January 17, 2017 - July 18, 2018

Phase

Phase 3

Additional info

Study Type

Interventional